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THE CHEMICAL SYNTHESIS OF AN ENZYME* 
BRUCE MERRIFIELD 
The Rockefeller University, New York, New York 
I. INTRODUCTION 
T
HE complexity of the proteins presents an unparalleled challenge 
to the synthetic chemist, and it is only recently that he has been in 
a position to respond in a meaningful way. Until now essentially 
all that has been learned about this class of compounds has come 
from studies on the naturally occurring proteins themselves. The 
accumulated body of knowledge is enormous, and very much is 
known about the composition and structure of the proteins and 
how they function. There are certain questions, however, which 
cannot be answered easily in this way and for these questions the 
synthetic approach should provide a valuable alternative. If we 
could learn how to synthesize proteins in the laboratory it should 
become possible to make specific, well defined changes in their 
structures which could give answers that are hard to derive from 
studies on the native molecules. In certain special cases, such as 
the unusually reactive residues at the active sites of enzymes, it 
has been possible to modify individual amino acid\ residues selec­
tively, but suppose it were to become important to modify or replace 
one particular valine residue in the protein; methods simply are not 
available to carry out such changes in the presence of many other 
similar groups within the same very sensitive macromolecule. 
The three-dimensional structure of a small protein, ribonuclease, 
is shown in Fig. 1 to illustrate the kind of molecule we are talking 
about and to illustrate the magnitude of the synthetic task. This 
crystalline molecule (Kunitz, 1940) contains 124 amino acids in a 
single polypeptide chain, cross-linked by four disulfide bonds, with 
1852 atoms precisely arranged in space in a well defined three­
dimensional structure. A chemical synthesis of ribonuclease A means, 
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Fm. 1. The three-dimensional structure of bovine pancreatic ribonuclease. Taken 
from the model of RNase S by Wyckoff et al. (1967) which was deduced from X-ray 
diffraction data at 3.5 A resolution and chemical sequence data. The heavy tubing
outlines the general contours of the polypeptide backbone, and the fine wire structures 
show the positions of the amino acid side chains. Reproduced by permission of the 
American Society of Biological Chemists, Inc. 
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therefore, that each of these atoms must be assembled in the labora­
tory into exactly this same sequence and structure. An understanding 
of the problem can be greatly simplified, first, by looking at a two­
dimensional picture in which the amino acid residues, rather than 
the individual atoms, are indicated as the basic units of the structure 
(Fig. 2) and, second, by recalling the important hypothesis of 
Anfinsen and his associates (White, 1961; Epstein et al., 1962) that 
the tertiary structure of this protein is determined by its primary 
structure. Thus, there was good reason to believe that if the amino 
acids could be assembled into the correct sequence the resulting 
molecule would direct its own folding and cross-linking to give the 
native protein, and a total synthesis of an enzyme would have been 
achieved. 
In principle, a protein can be synthesized by either of two general 
approaches; by the classical method or by the solid phase method. 
The classical method (see Schroder and Liibke, 1965) involves the 
preparation of small peptides (fragments), the combination of these 
small fragments into larger peptides, and eventually the assembly of 
the larger fragments into the final protein molecule. All these 
reactions are carried out in homogeneous solution, and the essential 
feature of this technique is the opportunity to isolate and purify 
the product after each reaction. This helps to ensure high purity 
and careful identification of intermediates. 
The most dramatic application of the classical technique to the 
synthesis of a protein occurred in the period between 1963 and 1965, 
with the nearly simultaneous synthesis of insulin by groups in 
Germany, the United States, and China (Meienhofer et al., 1963; 
Katsoyannis et al., 1964; Kung et al., 1965). At the present time, 
syntheses of proinsulin, ribonuclease T1, staphylococcal nuclease, 
myoglobin, growth hormone and, no doubt, several other proteins 
are under way. As far as I know none of these has been completed, 
but two or three can be expected soon. The problems, of course, are 
enormous. Large numbers of synthetic reactions and purification 
steps are involved, and much time, expense, and manpower is 
required. 
A variation of the strictly classical method, in which very rapid 
Leuchs anhydride couplings were employed, was applied success­
fully to the synthesis of S-protein (residues 21-124 of ribonuclease) 
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Fm. 2. The two-dimensional structure of bovine pancreatic ribonuclease A, showing the linear, 124 amino acid residue polypeptide chain cross-linked by the four disulfide bonds. The amino acids are indicated by their three-letter abbreviations. From Smyth et al. (1963), by permission of The American Society of Biological Chemists, Inc. 
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by Hirschmann et al. (1969). This accelerated technique eliminated 
the need for isolation of every intermediate, but permitted the 
isolation and purification of protected fragments. After noncovalent 
binding with·S-peptide (residues 1-20) the resulting ribonuclease S 
possessed enzymatic activity. 
· The second general approach to the chemical synthesis of proteins
is called solid phase peptide synthesis (Merrifield, 1963, 1969). The
method was devised in our laboratory in an effort to overcome
certain of the difficulties encountered with the classical methods.
It is much faster and simpler to carry out and introduces sizable
savings in manpower and materials. It has made possible our syn­
thesis of ribonuclease A (Gutte and Merrifield, 1969, 1971). I would
like to describe this technique in some detail and to discuss some of
the difficulties and problems associated with it as well as some of
the achievements.
II. Soun PHASE PEPTIDE SYNTHESIS 
The basic idea of the solid phase method is outlined in Fig. 3. 
It depends on the use of an insoluble solid support. The plan was to 
begin with an insoluble particle, indicated by the large circles, to 
functionalize it with a group, x, and to attach the first amino acid 
of the proposed peptide chain with a stable covalent bond by reaction 
at x. In practice we attach at the carboxyl of the amino acid (with 
the amino group protected), although in principle the attachment 
can also be at the amino group. The amino group is then depro­
tected, and the second amino acid is added to the first by a suitable 
peptide-forming reaction. In a similar way the subsequent amino 
acids are combined in a stepwise manner until the entire sequence 
has been assembled. Finally, the bond holding the peptide chain to 
the solid support is selectively cleaved, together with most side 
chain protecting groups, and the peptide is liberated into solution. 
The advantage that I envisioned for this approach was the oppor­
tunity to purify intermediates after each reaction by simple, rapid 
washing procedures. Since the growing peptide chain would be 
completely insoluble as a consequence of its attachment to the large 
insoluble support, it could be filtered and washed with large vol­
umes of solvents to remove reagents and by-products with no danger 
of losing the desired molecule. A related advantage, which was the 
real driving force behind the project, was the possibility that the 
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COOH 
Fm. 3. The basic idea of solid phase peptide synthesis. The large circle represents 
the solid support, the small open circles represent amino acid residues, and the dark 
circles represent protecting groups and activating groups. From Merrifield, 1971, by 
permission of Gordon and Breach, New York. 
process could be automated and thereby introduce further efficiency 
into the synthesis. It only remained to translate the general idea 
into a workable set of reactions. 
The support which we have found to be most satisfactory is a 
copolymer of styrene and divinylbenzene, containing 1 or 2% of 
the cross-linking agent. The resulting beads are illustrated in Fig. 4. 
They are about 50 µm in diameter when dry and swell to nearly 
8 times their volume in organic solvents such as the halogenated 
hydrocarbons. This means that the polystyrene chains are highly 
solvated during the chemical reactions and are readily accessible to 
diffusing reagents. The reactions occur not only at the surface of 
the bead, but, in major part, within the interior matrix of the bead. 
This could be readily demonstrated by autoradiography (Merrifield 
and Littau, 1968) of cross sections of beads containing a peptide in 
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which tritiated praline had been incorporated. The gross distri­
bution of peptide chains was quite uniform throughout the sections. 
The technique did not, however, have the resolving power to show 
the distribution at the molecular level and heterogeneity at that 
resolution is probable. 
Many detailed chemical schemes have been devised to carry out 
solid phase synthesis. An early one which proved to be very useful 
is shown in Fig. 5. The aromatic rings of the styrene can be deriva­
tized in several ways in order to provide an attachment site for the 
first amino acid. The first successful derivative was obtained by 
Styrene- diviny I benzene Copolymer 
Fm. 4. The styrene-divinylbenzene copolymer support. The spheres average about 
50 µm in diameter. 
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Fm. 5. A scheme for solid phase peptide synthesis. 
chloromethylation to give a substituted benzyl chloride which could 
be esterified by reaction with the triethylammonium salt of an 
N"-protected amino acid. The resulting benzyl ester was carefully 
chosen because it is quite stable for the remainder of the synthesis 
but can be selectively cleaved at the end with strong anhydrous 
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acid. In order to be compatible with the anchoring bond the amino 
protection should be relatively labile to acid, and the t-butyloxy­
carbonyl (Boe) group is commonly employed for that reason. It 
can be removed by 1 N HCl or by 20% trifluoroacetic acid in methyl­
ene chloride, for example. The resulting amine salt is neutralized by 
a tertiary amine, such as triethylamine, and is then ready to couple 
to the next Boe-amino acid to form the first peptide bond. Any one 
of a number of peptide-forming reagents can be applied. We have 
found dicyclohexylcarbodiimide (Sheehan and Hess, 1955) to be 
especially useful. Subsequent amino acids are incorporated in exactly 
the same way by alternately repeating the deprotection and coupling 
reactions. The last step is the cleavage of the peptide from the resin 
by acidolysis of the anchoring benzyl ester bond. Hydrogen bromide 
in trifluoroacetic acid or hydrogen fluoride (Sakakibara et al., 1967) 
are the methods of choice. 
Each of the steps described here has been modified in several 
ways both in this laboratory and in others (see Marshall and Merri­
field, 1971), and certain other changes are still necessary before the 
generally applicable, "ideal" system is evolved. 
The reaction sequences just described can be illustrated by the 
synthesis of bradykinin, which is outlined in Fig. 6 (Merrifield, 
1964). Bradykinin is a nonapeptide, derived from a plasma protein, 
with strong hypotensive and smooth muscle contracting properties. 
The solid phase synthesis began by attaching the protected C-termi­
nal amino acid, Boc-nitroarginine, to the polystyrene support and 
proceeded by carrying out the three basic steps of deprotection, 
neutralization and coupling, alternately, eight times each until the 
final peptide sequence was assembled. The peptide was released from 
the resin by anhydrous HBr in trifluoroacetic acid, and at the same 
time some of the protecting groups were also removed. The re­
mainder of the side chain protecting groups, in this case from the 
two nitroarginines, were removed by catalytic hydrogenation to 
give the crude bradykinin product. Purification by ion exchange 
chromatography finally gave analytically pure bradykinin, which 
was shown to have full biological activity when compared with 
the natural hormone. 
Following this early synthesis large numbers of analogs of brady­
kinin (Stewart and Woolley, 1966) and several other small peptide 




1 j N-HCI-HOAe 
8 times with: 3 
trea! altern_ately 2 
j Et N _ DMF 
Boe -Arg(N0
2
)- Pro - Pro- Gly- Phe- Ser(Bzl)-Pro -Phe-Arg(N0
2) - Resin 
j HB, -F ,CCOOH 
Arg(N0
2
) - Pro -Pro -Gly- Phe -Ser -Pro - Phe- Arg (N0
2) 
j H,, Pd 
Arg - Pro - Pro - Gly - Phe - Ser - Pro -Phe -Arg 
j ehromatoguphy 
BRADYKININ 
Fm. 6. A solid phase synthesis of bradykinin. 
hormones, such as angiotensin (Marshall and Merrifield, 1965) and 
oxytocin (Manning, 1968), have been synthesized by this same 
procedure and by various modifications of it. The method has been 
extended to insulin (Marglin and Merrifield, 1966) and to molecules 
such as ACTH, parathyroid hormone, secretin, valinomycin, trypsin 
inhibitor, several hormone-releasing factors, and a rather sizable 
number of model peptides for use in a variety of special problems. 
The requirements for a successful synthesis by the solid phase 
method are: (1) rapid reactions, (2) quantitative reactions, (3) no 
side reactions. We can approach these requirements, but obviously 
we do not quite realize them even in the best case. In spite of the 
fact that these are heterogeneous reactions, they are very fast (Fig. 
7), and there is no real problem in that regard. Some second-order 
rate constants for the coupling reaction have been measured which 
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indicate that 99% of the reaction between the hindered amino acids 
isoleucine and valine required 140 seconds, while the coupling was 
99% complete within 10 seconds for most unhindered amino acids. 
At the moment the most pressing problem is to devise precise, 
sensitive, and rapid methods to monitor the coupling reaction, 
because an indication of quantitative bond formation is crucial to 
the success of the method. A number of techniques are at hand, but 
no one of them meets all the requirements satisfactorily. It is obvi­
ously not sufficient to measure the disappearance of the amino acid 
reagent because it is present in excess at the outset of the reaction 






















Fm. 7. A rate curve for the coupling reaction. Coupling reaction: Bpoc-Gly­
anhydride (1.6 X 10-2 M) + Val-resin (0.8 X 10-2 M). k2 = 4.0 liters/mole• sec. 
Bpoc = biphenylisopropyloxycarbonyl. 
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are looking for an accurate measure of the last tenths or even 
hundredths of a percent of the reaction. A more sensitive test 
is the determination of the amount of unreacted peptide chain, and 
several ways to measure the terminal amino group have been de­
vised. It can be estimated by the ninhydrin reaction (Kaiser et al.,
1970) or, more quantitatively, by electrometric titration with per­
chloric acid (Brunfeldt et al., 1969) or by titration of its hydro­
chloride (Dorman, 1969) or picrate salt (Gisin, 1972) or by con­
version to a Schiff base and colorimetric assay of the aldehyde com­
ponent (Esko et al., 1968). 
A second important and continuing effort is directed toward the 
identification and elimination of side reactions. Several have been 
examined in detail and can now be avoided, while others remain 
as special problems. Racemization, for example, has been the uni­
versal worry of peptide chemists since the time of Fischer. Loss of 
optical purity ·in a biologically active peptide usually will lead to 
an inactive molecule, and in all cases it will result in a diastereomeric 
mixture which is exceedingly difficult to purify. This area has 
received a great deal of attention, and both conventional and solid 
phase syntheses can be designed which result in a negligible degree 
of racemization. It is a remarkably fortunate circumstance that the 
urethane protecting groups for amino acids, which are am-6ng the 
best derivatives for synthetic reasons, also confer high resistance to 
racemization. The accumulated evidence from many syntheses con­
firms the belief that there is essentially no racemization by way of 
oxazolone intermediates in solid phase syntheses. It was discovered 
recently, however, that urethane-protected histidine derivatives can 
give rise to appreciable amounts of racemic products both by con­
ventional couplings in solution and by solid phase couplings (Wind­
ridge and Jorgensen, 1971). The reaction probably proceeds by 
direct proton abstraction from the asymmetric a-carbon by the basic 
imidazole group, because the presence of an electron withdrawing 
substituent (dinitrophenyl) on the imidazole ring greatly reduced 
the effect. Work in our laboratory confirms their findings and shows 
that a p-toluene sulfonyl substituent on histidine essentially elimi­
nates the racemization problem (Lin et al., 1972). 
Dr. Gisin has recently discovered another side reaction during a 
solid phase synthesis and, by studying its mechanism, has devised a 
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way to eliminate it (Gisin and Merrifield, 1972). During the prepa­
ration of Boc-n-Pro-n-Val-L-Pro-resin it was observed that over 
70% of the peptide had been lost from the resin. By examining each 
of the steps in the synthesis, it was found that the loss occurred 
during tht= customary 10-minute equilibration treatment of n-Val-L­
Pro-resin with Boc-n-Val prior to addition of the coupling reagent. -
It was then shown that the product was n-Val-L-Pro-diketopipera­
zine and that its formation was strongly catalyzed by carboxylic 
acids-in this case by Boc-n-Pro (Fig. 8). Imino acid-containing 
dipeptides, such as those containing praline or N-methylalanine, 
are especially susceptible to the diketopiperazine formation because 
of the small energy difference between the cis and tt;ans amide con­
formations. Once the problem was understood, a simple solution 
was forthcoming; the order of addition of reagents was reversed, 
the presence of free carboxylic acid was eliminated, and the catalysis 
of the ring closure was avoided. With this improvement Gisin has 
gone on to complete the stepwise solid phase synthesis of the very 
interesting valinomycin analog -[L-Val-n-Pro-n-Val-L-Pro]a-. This 
H-o-Vol-L-Pro-0-resin 
,,.. resin 0 
I 
,,..C=O CCH NH 




















--- L o-Vol-L-Pro] + HO-resin 
\ 
Fm. 8. The proposed mechanism for the acid-catalyzed formation of a diketo­
. piperazine. From Gisen and Merrifield (1972), by permission of the American Chemical 
Society, Washington, D.C. 
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is the first cyclic peptide composed entirely of amino acids that can 
selectively bind potassium and carry it from an aqueous solution 
into a hydrophobic organic phase. 
Because the solid phase method in its usual form does not allow 
isolation of intermediates, some people feel that it can never be 
applied to the synthesis of high molecular weight products. I believe 
that it can be utilized for such problems at the present time and 
that, through the improvements which are constantly being made, 
the continuous, stepwise approach will eventually be the method of 
choice. For those who prefer to isolate protected intermediates, we 
have devised a new solid phase-fragment approach (Wang and 
Merrifield, 1969) in which small protected peptides are prepared on 
a resin support and, following cleavage and purification, are coupled 
in solution to give larger peptides. This technique, therefore, com­
bines some of the best features of the solid phase and classical ap­
proaches into a unified procedure. In its initial and usual form, as 
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Fm. 9. A solid phase-fragment scheme. From Wang and Merrifield (1972), by 
permission of Munksgaard, Copenhagen. 
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or completely deprotected peptides following the cleavage step in 
strong acid. These products, of course, are not suited for further 
couplings because they contain functional side chains. To overcome 
the problem, three classes of protecting groups are needed which 
can be selectively removed, as illustrated in Fig. 9. The group on 
the a-amine must be readily removed at each step of the synthesis 
without loss of side chain protection or of the anchoring bond to 
the resin, and at the end of the synthesis it must be possible to cleave 
the anchoring bond without loss of side chain protection. Finally, 
after the intermediate protected peptide has been purified and coupled 
to other fragments it must be possible to completely deprotect the 
finished polypeptide. The scheme developed by Dr. Wang makes use 
of three greatly different degrees of acid stability. He uses the very 
labile biphenylisopropyloxycarbonyl (Bpoc) group of Sieber and 
Iselin (1968) for a-amine protection, relatively stable benzyl or tosyl 
groups for side chain protection, and a new linkage of intermediate 
stability for the carboxyl attachment. These groups differ by 3 and 
6 orders of magnitude in their susceptibility to acid and, therefore, 
allow the satisfactory synthesis of protected fragments. A recent 
synthesis of an eledoisin analog will illustrate this general approach 









was synthesized using Bpoc derivatives for the intermediate coupling 
steps and carbobenzoxy protection for the last step. The protected 
peptide was removed by 50% trifluoroacetic acid and was obtained 
as a pure crystalline product. It was coupled in solution with 
H-Leu-Met-OMe, crystallized, aminolyzed and finally deprotected
to give H-Lys-Phe-Phe-Gly-Leu-Met-NH2 • The pure product showed
the expected strong hypotensive action in the rat, which was equal
to that of natural eledoisin itself.
Until now I have not discussed the mechanical aspects of this 
technique except to say that it was because of this potential feature 
that the solid phase method was developed in the first place. The 
ability to purify by simple filtration and washing and the fact that 
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all reactions could be conducted within a single reaction vessel 
appeared to lend themselves ideally to a mechanized and automated 
process. Initially, a simple manually operated apparatus was con­
structed (Fig. 10), and later, together with Dr. Stewart, we designed 
and built the automated instrument shown in Fig. 11 (Merrifield 
et al., 1966). The essential features were the reaction vessel contain­
ing the resin with its growing peptide chain and the necessary 
plumbing to enable the appropriate solvents and reagents to be 
pumped in, mixed, and removed in the proper sequence. The me­
chanical events were under the control of a simple stepping drum 
programmer and a set of timers. This instrument has been used for 
the synthesis of many small peptides and for the synthesis of ribo­
nuclease A. In the past few years at least nine commercial instru­
ments have been constructed in several countries. They differ con­
siderably in detail, but are designed to carry out the same chemistry. 
Fm. 10. A manually operated reaction apparatus, showing the glass reaction 
vessel with a fritted-glass filter disk and side arm. The resin is suspended by a rocking 
motion about the horizontal axis. 
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Fm. 11. The automated peptide synthesizer. 
III. THE SYNTHESIS OF RrnoNUCLEASE A
159 
As a first step toward bringing to bear the synthetic approach to 
the study of enzymes we undertook the total synthesis of bovine 
pancreatic ribonuclease A (Gutte and Merrifield, 1969, 1971). This 
molecule, which has been so closely associated with this institution, 
was well suited for the synthetic work because it is small and 
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Fm. 12. Protected ribonuclease A. 
CHEMICAL SYNTHESIS OF AN ENZYME 161 
stable and its amino acid sequence (Hirs et al., 1960; Smyth et al., 
1963) and X-ray crystallographic structure were known (Kartha 
et al., 1967; Wyckoff et al., 1967, 1970). 
The formula in Fig. 12 shows the protected derivative of ribo­
nuclease which we wished to synthesize. It contains a total of 67 
side chain protecting groups, largely based on benzyl derivatives for 
stability, and has a molecular weight of 19,791. The synthesis 
carried out by Dr. Gutte followed essentially the same procedure 
as that outlined in Fig. 5, while the workup, identification, and 
analysis of the product utilized a variety of techniques. The synthe­
sis, which has already been described in complete detail (Gutte and 
Merrifield, 1971), is summarized in Table I. It shows that the 
overall yield was about 3%, i.e., of the first amino acid, valine, 
originally attached to the resin 3% was eventually recovered in the 
TABLE I 
RIBONUCLEASE A SYNTHESIS 
Overall yield 
Stage of synthesis Mg % 
Boe-Val-Resin 2000 100 
l lkprntect I Neutralize j Repeat 123 times Couple 
17% Protected RNase-Resin 3430 17 i Cleave =d · deprntect 
HF 
71% Crude RN ase (SH)s 697 12 
53% t 
Sephadex G-75 
RNase A (monomer fraction) 373 6.4 69% i Trypsin digestion Sephadex G-50 
RN ase A (Trypsin resistant fraction) 66% tCNH4)2S04 fractionation 
256 4.4 
RNase A 169 2.9 
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final purified protein. A large accumulated loss occurred during the 
synthesis itself. This means that the benzyl ester bond anchoring 
the peptide to the resin was not entirely stable to the repeated 
acidic conditions of the synthesis and was lost to the extent of 
about 1.4% at each cycle. I must emphasize that this has nothing 
to do with the individual coupling yields, which we believe were 
high. The cleavage step and the numerous workup steps taken 
together accounted for another 80% loss of material. The quantities 
of ribonuclease indicated in Table I are the calculated amounts of 
product that would have been obtained if all the material had 
been carried through all these steps. During this work the material 
was divided into many fractions in order to work out the best 
procedures and to obtain analytical samples, so that the most ribo­
nuclease available at any time was of the order of 25 mg. When 
the crude HF-cleaved protein was oxidized and fractionated on an 
IRC-50 column in phosphate buffer it showed a large peak containing 
the enzymatic activity and two small· inactive peaks. The specific 
activity could not be raised above 13% by recycling through this 
column. We then decided to take advantage of the known stability 
of ribonuclease A to trypsin digestion (Dubas and Thompson, 1938). 
The reasoning was that material with the correct structure would 
come through the treatment intact, while molecules with incorrect 
structures due to incomplete sequences or improper folding would 
give rise to a mixture of small molecules that could readily be 
separated from the native molecule (Fig. 13). To our great satis­
faction the activity of a crude sample treated in this way increased 
from 8% to 61%, while only 25% of the protein was actually 
removed. A further purification step involved an ammonium sulfate 
fractionation in which some amorphous material could be separated, 
and a lyophilized preparation possessing nearly 80% specific activity 
was finally obtained. Table II summarizes the activity data obtained 
at various stages of purification of the synthetic enzyme. It also 
shows how the total number of units of RNase activity increased 
as the purification proceeded. 
We interpret these data to mean that inhibitory peptides were 
present which were giving rise to low enzyme activity val�es and 
the crude preparation actually contained more enzyme than we had 
thought. The purified RNase A was then placed on a CM-cellulose 
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Fm. 13. Schematic view of the purification of synthetic ribonuclease A by trypsin 
digestion. 
column and compared with natural RNase A and reduced-reoxidized 
natural RNase A. They were identical by this criterion, which was 
the one first used by White (1961) to show that RNase A after 
reduction and reoxidation was indistinguishable from native RNase. 
His was the demonstration that led to the hypothesis that the 
primary structure of the protein determined its tertiary structure. 
Our synthesis provides a new kind of evidence for this hypothesis. 
The fact that the only information put into the synthesis was the 
linear sequence means that the primary structure must be sufficient 
TABLE II 
RrnoNUCLEASE A Acnv1TY 
Specific Total activity 
activity (mg RNase/2 gm 
Purification stage (%) resin) 
HF cleavage 2 14 
Sephadex G-75 9 33 
IRC-50 13 53 
Trypsin 61 156 
(NH4)2S04 78 132 
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TABLE III 
EVIDENCE FOR PURITY AND IDENTITY OF SYNTHETIC RN ASE A 
Technique 
1. Gel filtration
2. Ion-exchange chromatography 
3. Paper electrophoresis 
4. Amino acid analysis
5. Digested by papain + APM 
6. Resistant to trypsin digestion
7. Fingerprint of tryptic digest of
oxidized RN ase 
8. Neutralization of antibody 
9. Enzymatic assay 
Conclusion 
Similar molecular size 
Similar net charge 
Similar charge and size 
Similar amino acid compositiop 
No major racemization 
Compact folding 
Similar amino acid sequence 
Similar antigenic determinants 
High specific activity and similar 
substrate specificity 
to direct the final folding of the molecule into its active tertiary 
structure. By starting with free amino acids any objections to the 
original experiments based on retention of some residual confor­
mation after the reduction step which might serve to initiate the 
refolding are eliminated. The synthesis of an active enzyme con­
taining no substituents except amino acids also provides a new 
proof for the now well-established belief that enzymatic activity 
can be a consequence of a simple protein and that no other com­
ponents either known or unknown need be present. Not too many 
years ago such a view was vehemently opposed. 
What we cannot claim is that this synthesis constitutes a proof 
of structure for ribonuclease A. Such a proof in the classical organic 
chemistry sense wiU be very difficult indeed because it is virtually 
impossible with present methods to establish absolute identity be­
tween two macromolecules of such complexity. 
The various kinds of evidence that have been obtained to establish 
the identity and purity of the synthetic RNase A are listed in Table 
III. Clearly, each of these tests has limitations and we can only say
that within these limits the synthetic preparation closely resembles
native ribonuclease A in its chemical and physical properties, that
it has a high specific activity and that it shows the expected sub­
strate specificity.
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IV. STRUCTURE FUNCTION STUDIES 
As I indicated earlier, one of the prime objectives of synthetic 
work on proteins is to develop the methods and capability to 
investigate various questions that are not easy to examine by studies 
of the naturally occurring proteins themselves. The synthesis of 
ribonuclease A has provided answers to some rather fundamental 
questions, and we feel that it has laid a foundation for new studies 
on structure-function relations in enzymes. As a bare beginning, I 
would like to discuss two such studies. 
In considering the well known S-peptide/S-protein system dis­
covered by Richards (1955, 1958), in which these two inactive 
components can recombine noncovalently to produce a fully active 
enzyme, we wondered whether the recombination would occur if 
the protein component were shortened at its amino terminus by the 
removal of residues 21 through 25, and whether the complex would 
be enzymatically active. To test this question a sample of peptide­
resin containing residues 25-124 was removed during the RNase 
synthesis, and another containing residues 21-124 was removed 
after the addition of 5 more residues (Fig. 14). These two synthetic 












Fm. 14. The S-peptide, S-protein, des 21-25 S-protein system. From Gutte and 
Merrifield (1970), by permission of The American Society of Biological Chemists, Inc. 
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were partially purified on Sephadex and then reduced at their 4 
disulfide bonds. The resulting random coils were mixed with S-pep­
tide (natural or synthetic), reoxidized and assayed for enzyme 
activity. The crude mixtures were both found to have approxi­
mately 25% as much activity as the product derived from native 
S-protein by the same treatment. From these data we can say,
qualitatively, that the first five residues, 21-25, are definitely not
necessary for the binding and reactivation to occur and, quanti­
tatively, that there is probably no appreciable effect whether they
are present or absent. Wyckoff and Richards had already predicted
from their X-ray data that the three serines at positions 21, 22, and
23 would probably not be necessary since there was no indication
of noncovalent interactions with other residues in the crystal. In
contrast, asparagine 24 and tyrosine 25 appeared to be involved in
a total of 5 hydrogen bonds, and it was reasonable to expect that
they would be important in stabilizing the complex between S-pep­
tide and S-protein and might be necessary for the formation of an
active complex. Our data indicate that those bonds are not required
either for binding or activity.
About 5 years ago I became interested in the question of whether 
or not i peptide component from the carboxyl end of ribonuclease 
might function in a manner analogous to that of S-peptide at the 
amino end. This was a good problem for synthesis because there 
was no enzyme available to make the necessary cleavage in the 
vicinity of residue 111. Consequently, Dr. Gutte synthesized the 
RNase 111-124 tetradecapeptide, H-Glu-Gly-Asn-Pro-Tyr-Val-Pro­
Val-His-Phe-Asp-Ala-Ser-Val-OH, and obtained it in a high state 
of purity. To test its ability to bind and activate an inactive protein 
component he prepared N 1-carboxymethyl histidine-119-RNase. 
Many attempts to reactivate this protein by addition of the peptide 
met with uniform failure. It appeared that the peptide was unable 
to displace the tail of the protein and to bind in its place in a way 
that would place His119 in a proper position to function catalytically. 
The problem was set aside while the work on the total synthesis of 
RNase proceeded, but was resumed about two years later when 
Lin et al. (1968) succeeded in preparing a series of shortened RNases. 
They made RN ase 1-120 by peptic digestion and RN ase 1-119 and 
RNase 1-118 by further digestions with carboxypeptidase A. When 
100 


















.,,, ...... - l 
/' des-(120-124)-RNase
,//2/ -------------r------0,, ____ -o- des-(121-124)-RNase1,x• 
�-----11 ,6'o 




2 3 4 5 6 7 
Peptide (111-124): protein molar ratio
167 
8 
Fm. 15. Enzymatic activity of the synthetic RNase 111-124 tetradecapeptide with
shortened ribonucleases. From Lin et al. (1970), by permission of The American Society
of Biological Chemists, Inc. 
the synthetic peptide 111-124 was assayed in the presence of these 
inactive proteins, high enzymatic activity was regenerated (Fig. 15). 
Through a joint effort with Lin, Moore, Gutte, and Caldi, we have 
studied the combination of a number of carboxyl-terminal peptides 
with the shortened protein components and have been able to 
answer a number of interesting questions (Lin et al., 1970, 1972; 
Gutte et al., 1972). These experiments can be discussed best by 
referring to Fig. 16. This shows how we visualize the peptide in­
serting itself into the three-dimensional structure of the protein to 
produce an active enzyme. As can be seen there are 8-10 overlapping 
residues between the two components, and we naturally wondered 
how long a peptide was actually required to produce the effect. A 
series of C-terminal peptides was therefore synthesized and tested 
in the presence of RNase 1-118 (Table IV). With peptides containing 
7 or 8 residues there was very little activity, but the addition of 
Val 116 made a dramatic increase to 60%. Further lengthening of the 
chain increased the binding gradually to a maximum of 98%. The 
role of Val 116 is now being examined in more detail to try to de-
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Fm. 16. Schematic representation of peptide-protein complexes in reconstituted 
ribonuclease. The drawing is based on the X-ray structure of RNase A by Kartha 











EFFECT OF CHAIN LENGTH oN Acnv ATION OF 
RN ASE 1-118 WITH COOH-TERMINAL PEPTIDES 
Activitya 








a Maximum activity, in presence of excess peptide, relative to an equimolar amount 
of native RNase A. From Gutte et al. (1972), by permission of the Amerian Society 
of Biological Chemists, Inc. 
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termine whether it is simply a matter of peptide length or whether 
there is a unique function for valine itself. 
Notice that in the combination of peptide 111-124 with protein 
1-119 or protein 1-120 there is a His119 in both components. Since
His119 is known to be involved in the catalytic mechanism of ribo­
nuclease (Crestfield et al., 1963) the question arose as to which of
these residues was participating in the reconstituted complexes.
Evidence was obtained by examining the alkylation pattern of the
complexes after treatment with iodoacetate (Table V). Native ribo­
nuclease alkylates either at His12 or His119 , in a ratio of about 1 to 7,
and the extent of alkylation correlates with the enzymatic activity
of various derivatives of RNase; thus RNase 1-120 has very low
activity and is poorly alkylated while RNase 1-119 is inactive and
is not alkylated under these conditions. It was found that the com­
plex between peptide 111-124 and RNase 1-120 was alkylated at
His119 of the protein component and also at His119 of the peptide in
a ratio of about 1 to 4, and the complex between peptide 111-124
TABLE V 
ALKYLATION OF HISTIDINE RESIDUES IN THE RECONSTITUTED COMPLEXES 
Site of alkylation 
Components His12 His119 
Protein Peptide Protein Protein Peptide 
RNase 1-124 (native RNase A) 0.12 0.77 
RNase 1-120 0.20 0.06 
RNase 1-119 0 0 
RNase 1-120 + RNase 111-114 0.14 0.24 0.06 
RNase 1-119 + RNase 111-124 0.10 0.50 0.40 
RNase 1-118 + RNase 111-124 0.10 0.70 
RNase 1-118 + [Ile120]RNase 111-124 0.10 0.07 
a Determined by measurement of the number of moles of N3-His(Cm) 
or N 1-His(Cm) per mole of protein. The N3-His(Cm) is assumed to occur 
only at His12 of the protein and N1-His(Cm) only at His119 of the protein 
or peptide. From Gutte et al. (1972), by permission of The American 
Society of Biological Chemists, Inc. 
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and RNase 1-119 alkylated to nearly the same extent in both com­
ponents. We interpret this to mean that these complexes exist in at 
least two conformations in which the peptide His119 is functioning 
catalytically part of the time and the protein His119 is functioning 
part of the time. Since dissociation constants could be measured, 
the two conformational forms must be in equilibrium with one 
another. In the case of peptide 111-124 and protein 1-118 there is 
only one His119 , and all of the alkylation occurred in the protein. 
A third question which we have studied by synthesis concerns 
the -role of Phe 120 . This residue is known to stabilize ribonuclease 
and was expected to be involved in binding_ the synthetic peptides to 
the shortened RNase molecules. There is also evidence from X-ray 
and nuclear magnetic resonance studies that Phe120 is located very 
close to the pyrimidine ring of the substrate and may be involved 
in binding substrate to RNase. We have obtained evidence on these 
points by synthesizing replacement analogs and combining them 
with RNase 1-118, (Table VI). Phe120 in the peptide 111-124 was 
replaced by the hydrophobic but nonaromatic residues leucine and 
isoleucine and by the large aromatic residue tryptophan. It was 
found that the dissociation constant, Kd, increased by a factor of 12 
when Leu120 was present, by 20 when Ile 120 was present, and by 
TABLE VI 
EFFECT OF PHE120 REPLACEMENTS ON THE DISSOCIATION CONSTANT OF THE 
PEPTIDE-PROTEIN COMPLEXES AND ON THE MICHAELIS CONSTANT AND 
INHIBITOR DISSOCIATION CoNSTANTa 
Km K; 
Kd for C > p for 2' Cp 
Components of the complex (M) (M) (M) 
RNase A 0.7 X 10-3 0.9 X 10-s 
[Phe120]RNase 111-124 + RNase 1-118 2.0 X 10-7 0.7 X 10-3 
[Leu120JRNase 111-124 + RNase 1-118 2.5 X 10-s 1.0 X 10-3 
[Ile120]RNase 111-124 + RNase 1-118 4.0 X 10-s 1.2 X 10-3 1.1 X 10-5 
[Trp120JRNase 111-124 + RNase 1-118 3.5 X 10-s 
a From Lin et al. (1972), by permission of The American Society of Bio­
logical Chemists, Inc. 
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170 when Trp120 was present, suggesting a failure to fit properly 
into the hydrophobic pocket normally occupied by Phe120 • Further­
more, even when the peptide was present in saturating concentra­
tions, full enzymatic activity could not be regenerated by these 
peptide analogs. It therefore appears that phenylalanine plays a 
very important role in binding the carboxyl end of ribonuclease to 
the remainder of the protein and in properly aligning the catalytic 
site. 
To obtain information about the role of Phe120 in binding sub­
strate, the Michaelis constant, Km, for 2', 3' -cyclic cytidylic acid 
and the substrate inhibition constant, Ki, for 2'-cytidylic acid were 
examined. These values are related to the strength of binding 
of substrate to the enzyme complex. Within the experimental error, 
Km, was essentially the same for native RNase and for the complexes 
containing Phe, Leu, or Ile at position 120, indicating that phenyl­
alanine had no unique role in binding substrate, and that if it played 
any part in the binding its role could be equally well assumed by 
leucine or isoleucine. A similar conclusion could be reached from 
the inhibition constant for 2'-cytidylic acid which was nearly the 
same whether Phe120 or Ile120 was present. 
The final experiment I would like to mention concerns the as­
sembly of a three-component enzyme (Fig. 16). We discovered that 
S-peptide (1-20), containing His12, and the C-terminal peptide
(111-124), containing His119, could be mixed in solution with RNase
(21-118), containing Lys41 , and that they would bind noncovalently
to produce a complex possessing about 30% specific activity. Thus,
three separate peptides, each containing one of the amino acids
known to function in the catalytic mechanism of ribonuclease,
could reassociate in a very specific way to reconstitute the catalytic
site and the substrate binding site and produce the active enzyme.
V. CONCLUSIONS 
I have described a new approach to peptide synthesis, called 
solid phase peptide synthesis, and have indicated some of its virtues 
and some of the disadvantages and problems associated with it. The 
application of this technique to the synthesis of small peptides was 
described, and its use in the first total synthesis of an enzyme was 
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discussed. Finally, some examples were presented to show how the 
synthetic approach can be used to answer questions about the 
structure and function of proteins. 
It is now possible to synthesize true proteins with real enzymatic 
activity beginning with simple amino acids. I believe that in the 
years ahead we will see a great deal of progress in this area which 
will contribute in a significant way to our understanding of this 
very important class of compounds. 
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